KULKARNI SANDEEP CHIDAMBAR (CEO) purchased 1.3% of their position (9.65K shares) of TOURMALINE BIO, INC. on the open market
Open‑market purchase worth $110.9K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 10/26/2023ACC: 0001209191-23-053691
DirectorOfficer· CEO
Since Oct 2023
+9.65K
Net shares
Net buyer
$110.9K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
9.65K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+4.65K
Price / share
$10.68
Trade value
$49.66K
% of position
0.6%
10/24/2023
716.09K→720.74K
Common Stock
Direct
Shares
+5K
Price / share
$12.25
Trade value
$61.25K
% of position
0.7%
10/26/2023
720.74K→725.74K
Total
Net shares
+9.65K
Net value
$110.91K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/24/2023 | P · Purchase | +4.65K | $10.68 | $49.66K | 0.6% | 716.09K | 720.74K |
| Common Stock Direct | 10/26/2023 | P · Purchase | +5K | $12.25 | $61.25K | 0.7% | 720.74K | 725.74K |
| Total | +9.65K | $110.91K | ||||||
Derivative Transactions0
No derivative transactions reported